Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Arisaema heterophyllum

ABSTRACT: Arisaema heterophyllum Genome sequencing and assembly

PROVIDER: PRJNA838258 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19217012_1.fastq.gz	Fastqsanger.gz
	SRR19217012_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Arisaema heterophyllum

Project description:Arisaema heterophyllum overview

| PRJNA838675 | ENA

Arisaema heterophyllum

Project description:De novo sequencing and assembly of Arisaema heterophyllum Blume transcriptome

| PRJNA411914 | ENA

Arisaema amurense

Project description:Arisaema amurense Genome sequencing and assembly

| PRJNA1036542 | ENA

Arisaema decipiens

Project description:Arisaema decipiens overview

| PRJNA832004 | ENA

Arisaema erubescens

Project description:Arisaema erubescens overview

| PRJNA1095076 | ENA

Project description:Genome skimming of Arisaema heterophyllum

| PRJNA743035 | ENA

Arisaema decipiens

Project description:Arisaema decipiens Raw sequence reads

| PRJNA831574 | ENA

Arisaema erubescens

Project description:Arisaema erubescens Raw sequence reads

| PRJNA622898 | ENA

Arisaema decipiens

Project description:Arisaema decipiens Raw sequence reads

| PRJNA831624 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data